Gefitinib 184475-35-2
-
Post Date:
May 07,2019
-
Expiry Date:
Nov 03,2019
-
Detailed Description:
Cas No. :184475-35-2
Gefitinib is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. However, meta-analyses have not shown any improvement in overall survival, that is, it does not extend life.
-
CAS Registry Number:
184475-35-2
-
Synonyms:
;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib, Iressa, ZD1839;Gefitinib Base;Geftinib;
-
Molecular Formula:
C22H24ClFN4O3
-
Molecular Weight:
446.9024
-
Molecular Structure:
Inquiry
主站蜘蛛池模板:
新田县|
舒兰市|
永修县|
原阳县|
平果县|
开封市|
双桥区|
抚宁县|
若尔盖县|
城口县|
石台县|
顺义区|
习水县|
福贡县|
汕尾市|
克东县|
甘谷县|
堆龙德庆县|
五大连池市|
前郭尔|
永新县|
怀来县|
南乐县|
县级市|
永定县|
格尔木市|
合水县|
柳河县|
长沙县|
临夏县|
余姚市|
从化市|
沙雅县|
南皮县|
江西省|
嘉鱼县|
拉萨市|
澎湖县|
仙居县|
宁远县|
山东省|